News

Under the settlement agreement, PDL paid MedImmune $65m on 15 February 2011 and will pay $27.5m by 10 February 2012 for a total of $92.5m. MedImmune has not

Tivozanib is designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers. Under the terms of

The companies will also introduce Computer-Assisted Physician Documentation (CAPD) technology to provide breakthrough advancements in clinical document improvement (CDI). The idea is to establish CAPD use as a

Results showed nearly 80% protective efficacy against the influenza strains contained in the vaccine and a low adverse event profile. PREFLUCEL significantly reduced duration and severity of influenza

NorLevo, which can now be dispensed directly to women in Irish pharmacies, is a levonorgestrel-only emergency contraceptive pill introduced in France in 1999. The product does not contain

Covance and Quintiles will work in close partnership with Takeda to plan and execute global development programs which will support new compounds in all therapeutic areas, except oncology.

Pfenex Expression Technology platform is based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. Under the multi-year agreement, Pfenex

The Fluidigm Access Array System is an automated sample preparation system for next-generation sequencing that provides parallel amplification of 48 unique samples, in effect preparing 48 sequencing libraries,

One of the independent venture capital firms participating in the Portfolio has acquired two molecules and will oversee the next stage of their development. The first is a